Citation from the publications of

Kuzniecky, R; Pan, J; Burns, A; Devinsky, O; Hetherington, H
"Levetiracetam has no acute effects on brain gamma-aminobutyric acid levels"
Epilepsy & behavior 2008 Feb; 12(2):242-244
OBJECTIVE: The mechanism of action of levetiracetam (LEV), an antiepileptic drug, is related to a novel binding site, SV2, but LEV acts on GABA-A receptors. The objective of the study described here was to determine if LEV modulates brain GABA in vivo. METHODS: Concentrations of cerebral GABA and serum LEV were obtained in seven healthy individuals using 1H magnetic resonance spectroscopy at baseline and 3 and 6 hours following oral administration of 1 g of LEV. RESULTS: Brain cerebral GABA acutely concentrations did not change from baseline. CONCLUSION: The results indicate that LEV does not increase human cerebral GABA concentrations acutely in healthy individuals

Check for full text:  

# 76394 (MEDL:18286712)


This publication list a product of the NYU Faculty Bibliography.